Leiomyosarcoma Clinical Trials Leiomyosarcoma RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)
Condition:   Leiomyosarcoma Interventions:   Drug: Unesbulin;   Drug: Dacarbazine;   Other: Placebo Sponsor:   PTC Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2022 Category: Research Source Type: clinical trials